Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model.
Kim YH, Moon JY, Kim EO, Lee SJ, Kang SH, Kim SK, Heo K, Lee Y, Kim H, Kim KT, Kim D, Song MS, Lee SW, Lee Y, Koh SS, Kim IH. Kim YH, et al. Among authors: kim ih, kim h, kim d, kim sk, kim kt, kim eo. Cancer Lett. 2014 Mar 28;344(2):223-31. doi: 10.1016/j.canlet.2013.10.028. Epub 2013 Nov 1. Cancer Lett. 2014. PMID: 24189457
Image-aided Suicide Gene Therapy Utilizing Multifunctional hTERT-targeting Adenovirus for Clinical Translation in Hepatocellular Carcinoma.
Kim YH, Kim KT, Lee SJ, Hong SH, Moon JY, Yoon EK, Kim S, Kim EO, Kang SH, Kim SK, Choi SI, Goh SH, Kim D, Lee SW, Ju MH, Jeong JS, Kim IH. Kim YH, et al. Among authors: kim ih, kim d, kim s, kim sk, kim kt, kim eo. Theranostics. 2016 Jan 6;6(3):357-68. doi: 10.7150/thno.13621. eCollection 2016. Theranostics. 2016. PMID: 26909111 Free PMC article.
Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study.
Woo SM, Kim MK, Joo J, Yoon KA, Park B, Park SJ, Han SS, Lee JH, Hong EK, Kim YH, Moon H, Kong SY, Kim TH, Lee WJ. Woo SM, et al. Among authors: kim yh, kim th, kim mk. Cancer Res Treat. 2017 Oct;49(4):1022-1032. doi: 10.4143/crt.2016.495. Epub 2017 Jan 19. Cancer Res Treat. 2017. PMID: 28111423 Free PMC article.
DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study.
Woo SM, Yoon KA, Hong EK, Park WS, Han SS, Park SJ, Joo J, Park EY, Lee JH, Kim YH, Kim TH, Lee WJ. Woo SM, et al. Among authors: kim yh, kim th. Oncotarget. 2017 Jul 6;8(46):81394-81404. doi: 10.18632/oncotarget.19037. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113399 Free PMC article.
Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas.
Yin J, Jung JE, Choi SI, Kim SS, Oh YT, Kim TH, Choi E, Lee SJ, Kim H, Kim EO, Lee YS, Chang HJ, Park JY, Kim Y, Yun T, Heo K, Kim YJ, Kim H, Kim YH, Park JB, Choi SW. Yin J, et al. Among authors: kim yh, kim ss, kim h, kim yj, kim th, kim eo, kim y. Cancer Lett. 2018 Feb 1;414:181-189. doi: 10.1016/j.canlet.2017.11.013. Epub 2017 Nov 15. Cancer Lett. 2018. PMID: 29154973
12,450 results
You have reached the last available page of results. Please see the User Guide for more information.